Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Status: Enrolling
Updated:  7/7/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Status: Enrolling
Updated: 7/7/2015
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
21
mi
from 91732
Beverly Hills, CA
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
21
mi
from 91732
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2306
mi
from 91732
Tamarac, FL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2306
mi
from 91732
Tamarac, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2703
mi
from 91732
Ellsworth, ME
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2703
mi
from 91732
Ellsworth, ME
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1966
mi
from 91732
Detroit, MI
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2432
mi
from 91732
Palisades Park, NJ
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2432
mi
from 91732
Palisades Park, NJ
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2435
mi
from 91732
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2435
mi
from 91732
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2435
mi
from 91732
New York, NY
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2090
mi
from 91732
Belmont, NC
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2090
mi
from 91732
Belmont, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2202
mi
from 91732
Durham, NC
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2126
mi
from 91732
Winston-Salem, NC
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
827
mi
from 91732
Portland, OR
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1297
mi
from 91732
McAllen, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1297
mi
from 91732
McAllen, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
1218
mi
from 91732
Temple, TX
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
1218
mi
from 91732
Temple, TX
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
570
mi
from 91732
Salt Lake City, UT
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
Clinical Research Facility
2122
mi
from 91732
Morgantown, WV
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
Clinical Research Facility
2122
mi
from 91732
Morgantown, WV
Click here to add this to my saved trials
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  7/13/2015
6113
mi
from 91732
Buenos Aires,
Efficacy and Safety of Adalimumab in Subjects With Active Uveitis
A Multicenter Study of the Efficacy and Safety of the Human Anti-TNF Monoclonal Antibody Adalimumab as Maintenance Therapy in Subjects Requiring High Dose Corticosteroids for Active Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 7/13/2015
6113
mi
from 91732
Buenos Aires,
Click here to add this to my saved trials
Electronic Patient Reported Symptom Assessment
Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
Status: Enrolling
Updated:  7/13/2015
Northwestern Memorial Hospital
1730
mi
from 91732
Chicago, IL
Electronic Patient Reported Symptom Assessment
Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
Status: Enrolling
Updated: 7/13/2015
Northwestern Memorial Hospital
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Status: Enrolling
Updated:  7/17/2015
Oklahoma University
1165
mi
from 91732
Oklahoma City, OK
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Status: Enrolling
Updated: 7/17/2015
Oklahoma University
1165
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York
Status: Enrolling
Updated:  7/21/2015
Roswell Park Cancer Institute
2181
mi
from 91732
Buffalo, NY
Breast and Cervical Cancer Educational Intervention for Latinas in Western New York
Investigating a Breast and Cervical Cancer Intervention for Latinas in Western New York
Status: Enrolling
Updated: 7/21/2015
Roswell Park Cancer Institute
2181
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
A Phase II Study of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Status: Enrolling
Updated:  7/25/2015
Ohio State University-Division of Gyn Oncology
1960
mi
from 91732
Columbus, OH
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
A Phase II Study of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Status: Enrolling
Updated: 7/25/2015
Ohio State University-Division of Gyn Oncology
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
Status: Enrolling
Updated:  8/3/2015
University Hospitals Seidman Cancer Center
2036
mi
from 91732
Cleveland, OH
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
A Phase 1 Study of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Body Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
Status: Enrolling
Updated: 8/3/2015
University Hospitals Seidman Cancer Center
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated:  8/3/2015
University of Arkansas
1463
mi
from 91732
Little Rock, AR
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
University of Arkansas
1463
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated:  8/3/2015
University Hospital Case Medical Center
2036
mi
from 91732
Cleveland, OH
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
University Hospital Case Medical Center
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated:  8/3/2015
University of Texas
1228
mi
from 91732
Dallas, TX
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
University of Texas
1228
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated:  8/3/2015
University of Texas
1400
mi
from 91732
Galveston, TX
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
University of Texas
1400
mi
from 91732
Galveston, TX
Click here to add this to my saved trials
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated:  8/3/2015
Eastern Virginia Medical School
2336
mi
from 91732
Norfolk, VA
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Feasibility Clinical Study: Accuracy of the P2X7 Biomarker in Detection of Endometrial Cancers in Women
Status: Enrolling
Updated: 8/3/2015
Eastern Virginia Medical School
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Status: Enrolling
Updated:  8/10/2015
Washington University
1569
mi
from 91732
St. Louis, MO
Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Randomized Phase II Study of Zoledronic Acid vs Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer
Status: Enrolling
Updated: 8/10/2015
Washington University
1569
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Status: Enrolling
Updated:  8/14/2015
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Pelvic IMRT With Tomotherapy: A Phase I Feasibility Study in Post-Hysterectomy Cervical Cancer Patients
Status: Enrolling
Updated: 8/14/2015
Washington University School of Medicine
1570
mi
from 91732
St. Louis, MO
Click here to add this to my saved trials
Bupropion in Helping Adults Stop Smoking
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated:  8/27/2015
Roswell Park Cancer Institute
2181
mi
from 91732
Buffalo, NY
Bupropion in Helping Adults Stop Smoking
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated: 8/27/2015
Roswell Park Cancer Institute
2181
mi
from 91732
Buffalo, NY
Click here to add this to my saved trials
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated:  8/31/2015
Univ of Nebraska Med Ctr
1300
mi
from 91732
Omaha, NE
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Univ of Nebraska Med Ctr
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated:  8/31/2015
Cleveland Clinic Foundation
2033
mi
from 91732
Cleveland, OH
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Cleveland Clinic Foundation
2033
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated:  8/31/2015
Northwestern University
1730
mi
from 91732
Chicago, IL
Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis
Open-Label, Safety and Tolerability Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle in Subjects With Non-Infectious Uveitis
Status: Enrolling
Updated: 8/31/2015
Northwestern University
1730
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
Status: Enrolling
Updated:  9/1/2015
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
Magnetic Resonance Elastography (MRE) of Uterine Fibroids
Status: Enrolling
Updated: 9/1/2015
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials